Prevalence of C77G polymorphism in exon 4 of the CD45 gene in the Spanish population;Prevalencia del polimorfismo C77G en el exón 4 del gen CD45 en la población española

Medicina Clinica

Volumn 125, Issue 1, 2005, Pages 10-11

  Gil, Juana ^a   Ruiz Tíscar, José Luis ^a   Rodríguez Sainz, Carmen ^a   Hernández, Ana ^a   Santamaria, Beatriz ^a   García Sánchez, Félix ^b   Fernández Cruz, Eduardo ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b Centro de Transfusión de la Comunidad de Madrid ^*  (Spain)

Author keywords

CD45; Polymorphism; Splicing

Indexed keywords

CD45 ANTIGEN;

ARTICLE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DNA SPLICING; EXON; FLOW CYTOMETRY; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMORY CELL; PREVALENCE; SPAIN; T LYMPHOCYTE;

EID: 21744452809     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13076408     Document Type: Article

References (10)

1. Hermiston ML, Xu Z, Weiss A. CD45: a critical regulator of signaling thresholds in immune cells. Ann Rev Immunology. 2003;21:107-37.
2. Tchilian EZ, Wallace DL, Wells RS, Flower DR, Morgan G, Beberley PCL. A deletion in the gene encoding the CD45 antigen in a patient with SCID. J Immunol. 2001;166:1308-13.
3. Schwinzer R, Wonigeit K. Genetically determined lack of CD45R- T cells in healthy individuals. J Exp Med. 1990;171:1803-8.
4. Zilch CF, Walker AM, Timón M, Goff LK, Wallace DL, Beberley PCL. A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans. Eur J Immunol. 1998;28:22-9.
5. Tchilian EZ, Dawes R, Ramaley PA, Whitworth JA, Yudasheva N, Wells RS, et al. A CD45 polymorphism associated with abnormal splicing is absent in African populations. Immunogenetics. 2002;53:980-3.
6. Jacobsen M, Hoffmann S, Cepok S, Stei S, Ziegler A, Sommer N, et al. A novel mutation on PTPRC interferes with splicing and alters the structure of the human CD45 molecule. Immunogenetics. 2002;54:158-63.
7. Gómez-Lira M, Liguori M, Magnani C, Bonamini D, Salviati A, Leone M, et al. CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers. J Neuroimmunol. 2003;140:216-21.
8. Tchilian EZ, Wallace DL, Dawes R, Imami N, Burton C, Gotch F, et al. A point mutation in CD45 may be associated with an increased risk of HIV-1 infection. AIDS. 2001;15:1892-4.
9. Carbone J, Gil J, Benito JM, Navarro J, Muñoz-Fernández A, Bartolomé J. et al. Increased levels of activated subsets of CD4+ T cells add to the prognostic value of low CD4+ T cell counts in a cohort of HIV-infected drug users. AIDS. 2000;14:2823-9.
10. Resino S, Navarro J, Bellón JM, Gurbindo D, León JA, Muñoz Fernández MA. Relación de las subpoblaciones de linfocitos T con los marcadores pronósticos de Ia infección pediâtrica por el virus de la inmunodeficiencia humana. Med Clin (Barc). 2001;117:216-7.